Want to join the conversation?
Artificial heart valve maker $EW reported higher 4Q15 results, mainly helped by demand for its transcatheter aortic valve replacement therapy. For the quarter, the company reported earnings of $140.7MM, or $0.64 per share, compared with earnings of $109.2MM, or $0.50 cents per share a year ago. Revenue rose 8.6% to $671.1MM.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.
$VZ down more than 2% after a disappointing third quarter. A lot of uncertainty on the Yahoo deal too.